title: A prescription survey in a hospital hypertension outpatient clinic.
abstract: OBJECTIVE
  The objective of this study was to investigate drug utilization in the management of hypertension in Hong Kong.
  
  
  METHODS
  We conducted a prescription survey to examine the use of antihypertensive drugs in a hypertension clinic in a regional hospital and the resulting expenditure incurred. The use of concurrent medications such as antidiabetic drugs and lipid-lowering agents was also examined.
  
  
  RESULTS
  During a 7-week study period, 530 prescriptions were collected. All except 14 patients received antihypertensive drugs with 262 (50.8%) on monotherapy and 254 (49.2%) on combination therapy. Calcium channel blocking agents and beta-adrenoceptor blocking agents were the two most popular antihypertensive drugs used in both monotherapy (38% and 31%, respectively) and combination therapy (27% and 33%, respectively). Forty-nine patients (19%) received three antihypertensive drugs or more. The number of antihypertensive drugs showed a significant positive correlation with the duration of attendance at the clinic (r=0.88, P < 0.001). Of the total 530 prescriptions, 5.6% and 10% contained antidiabetic drugs and lipid-lowering agents, respectively. Calcium channel blocking agents, angiotensin converting enzyme (ACE) inhibitors and lipid lowering agents, accounted for 82% (HK$211,654; pounds sterling 1 approximately HK$12) of the total drug expenditure (HK$258,115). Seventy-nine percent of the lipid lowering agents prescribed were hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors. Amlodipine accounted for 26% of usage but contributed to 41% of the overall costs of calcium channel blocking agents. Alpha1-adrenoceptor blocking agents were only used infrequently and were the most expensive class of drugs, due to the preferred use of doxazosin rather than prazosin which is far cheaper than the former.
  
  
  CONCLUSIONS
  In view of the use of these often costly drugs for long-term therapy, monitoring of their use and its correlation with clinical outcomes and quality of life is essential to ensure the optimal use of health care resources.
authors.affiliation: Department of Pharmacy, The Chinese University of Hong Kong, Shatin, New Territories.
authors.forename: P K
authors.initials: PK
authors.lastname: Lee
authors.forename: R K
authors.initials: RK
authors.lastname: Li
authors.forename: J C
authors.initials: JC
authors.lastname: Chan
authors.forename: S
authors.initials: S
authors.lastname: Chang
authors.forename: S C
authors.initials: SC
authors.lastname: Lee
authors.forename: B
authors.initials: B
authors.lastname: Tomlinson
authors.forename: J A
authors.initials: JA
authors.lastname: Critchley
mesh_terms: D000959:Antihypertensive Agents / Q000191:economics / Q000627:therapeutic use*; D011307:Drug Prescriptions / Q000191:economics; D004359:Drug Therapy, Combination; D004363:Drug Utilization; D005260:Female; D006723:Hong Kong; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000191:economics; D000960:Hypolipidemic Agents / Q000191:economics / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010044:Outpatient Clinics, Hospital / Q000191:economics
chemical_list: D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents